img

Global Porcine Circovirus Vaccine Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Porcine Circovirus Vaccine Market Insights, Forecast to 2034

Porcine circovirus (PCV) is a group of single-stranded DNA viruses (class II), that is nonenveloped with an unsegmented circular genome.
Global Porcine Circovirus Vaccine market is expected to reach to US$ 265 million in 2024, with a positive growth of %, compared with US$ 245 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Porcine Circovirus Vaccine industry is evaluated to reach US$ 409 million in 2029. The CAGR will be 7.5% during 2024 to 2029.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Covers
This report presents an overview of global Porcine Circovirus Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Porcine Circovirus Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Chopper Biology
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Jinyu Bio-Technology
Zoetis
Boehringer Ingelheim
Segment by Type
Genetic Engineering Vaccine
Killed Vaccines

Segment by Application


Piglets
Adults Pigs

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Porcine Circovirus Vaccine plant distribution, commercial date of Porcine Circovirus Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Porcine Circovirus Vaccine introduction, etc. Porcine Circovirus Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Porcine Circovirus Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Porcine Circovirus Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Porcine Circovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Genetic Engineering Vaccine
1.2.3 Killed Vaccines
1.3 Market by Application
1.3.1 Global Porcine Circovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Piglets
1.3.3 Adults Pigs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Porcine Circovirus Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Porcine Circovirus Vaccine Revenue by Region
2.2.1 Global Porcine Circovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Porcine Circovirus Vaccine Revenue by Region (2018-2024)
2.2.3 Global Porcine Circovirus Vaccine Revenue by Region (2024-2029)
2.2.4 Global Porcine Circovirus Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Porcine Circovirus Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Porcine Circovirus Vaccine Sales by Region
2.4.1 Global Porcine Circovirus Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Porcine Circovirus Vaccine Sales by Region (2018-2024)
2.4.3 Global Porcine Circovirus Vaccine Sales by Region (2024-2029)
2.4.4 Global Porcine Circovirus Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Porcine Circovirus Vaccine Sales by Manufacturers
3.1.1 Global Porcine Circovirus Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Porcine Circovirus Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Porcine Circovirus Vaccine in 2022
3.2 Global Porcine Circovirus Vaccine Revenue by Manufacturers
3.2.1 Global Porcine Circovirus Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Porcine Circovirus Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Porcine Circovirus Vaccine Revenue in 2022
3.3 Global Key Players of Porcine Circovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Porcine Circovirus Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Porcine Circovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Porcine Circovirus Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Porcine Circovirus Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Porcine Circovirus Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Porcine Circovirus Vaccine Sales by Type
4.1.1 Global Porcine Circovirus Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Porcine Circovirus Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Porcine Circovirus Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Porcine Circovirus Vaccine Revenue by Type
4.2.1 Global Porcine Circovirus Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Porcine Circovirus Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Porcine Circovirus Vaccine Price by Type
4.3.1 Global Porcine Circovirus Vaccine Price by Type (2018-2024)
4.3.2 Global Porcine Circovirus Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Porcine Circovirus Vaccine Sales by Application
5.1.1 Global Porcine Circovirus Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Porcine Circovirus Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Porcine Circovirus Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Porcine Circovirus Vaccine Revenue by Application
5.2.1 Global Porcine Circovirus Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Porcine Circovirus Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Porcine Circovirus Vaccine Price by Application
5.3.1 Global Porcine Circovirus Vaccine Price by Application (2018-2024)
5.3.2 Global Porcine Circovirus Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Porcine Circovirus Vaccine Market Size by Type
6.1.1 US & Canada Porcine Circovirus Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Porcine Circovirus Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Porcine Circovirus Vaccine Market Size by Application
6.2.1 US & Canada Porcine Circovirus Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Porcine Circovirus Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Porcine Circovirus Vaccine Market Size by Country
6.3.1 US & Canada Porcine Circovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Porcine Circovirus Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Porcine Circovirus Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Porcine Circovirus Vaccine Market Size by Type
7.1.1 Europe Porcine Circovirus Vaccine Sales by Type (2018-2029)
7.1.2 Europe Porcine Circovirus Vaccine Revenue by Type (2018-2029)
7.2 Europe Porcine Circovirus Vaccine Market Size by Application
7.2.1 Europe Porcine Circovirus Vaccine Sales by Application (2018-2029)
7.2.2 Europe Porcine Circovirus Vaccine Revenue by Application (2018-2029)
7.3 Europe Porcine Circovirus Vaccine Market Size by Country
7.3.1 Europe Porcine Circovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Porcine Circovirus Vaccine Sales by Country (2018-2029)
7.3.3 Europe Porcine Circovirus Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Porcine Circovirus Vaccine Market Size
8.1.1 China Porcine Circovirus Vaccine Sales (2018-2029)
8.1.2 China Porcine Circovirus Vaccine Revenue (2018-2029)
8.2 China Porcine Circovirus Vaccine Market Size by Application
8.2.1 China Porcine Circovirus Vaccine Sales by Application (2018-2029)
8.2.2 China Porcine Circovirus Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Porcine Circovirus Vaccine Market Size by Type
9.1.1 Asia Porcine Circovirus Vaccine Sales by Type (2018-2029)
9.1.2 Asia Porcine Circovirus Vaccine Revenue by Type (2018-2029)
9.2 Asia Porcine Circovirus Vaccine Market Size by Application
9.2.1 Asia Porcine Circovirus Vaccine Sales by Application (2018-2029)
9.2.2 Asia Porcine Circovirus Vaccine Revenue by Application (2018-2029)
9.3 Asia Porcine Circovirus Vaccine Sales by Region
9.3.1 Asia Porcine Circovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Porcine Circovirus Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Porcine Circovirus Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Porcine Circovirus Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Porcine Circovirus Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Chopper Biology
11.1.1 Chopper Biology Company Information
11.1.2 Chopper Biology Overview
11.1.3 Chopper Biology Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Chopper Biology Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Chopper Biology Recent Developments
11.2 ChengDu Tecbond
11.2.1 ChengDu Tecbond Company Information
11.2.2 ChengDu Tecbond Overview
11.2.3 ChengDu Tecbond Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 ChengDu Tecbond Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 ChengDu Tecbond Recent Developments
11.3 Ringpu Biology
11.3.1 Ringpu Biology Company Information
11.3.2 Ringpu Biology Overview
11.3.3 Ringpu Biology Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Ringpu Biology Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ringpu Biology Recent Developments
11.4 Qilu Animal
11.4.1 Qilu Animal Company Information
11.4.2 Qilu Animal Overview
11.4.3 Qilu Animal Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Qilu Animal Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Qilu Animal Recent Developments
11.5 DHN
11.5.1 DHN Company Information
11.5.2 DHN Overview
11.5.3 DHN Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 DHN Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 DHN Recent Developments
11.6 CAVAC
11.6.1 CAVAC Company Information
11.6.2 CAVAC Overview
11.6.3 CAVAC Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 CAVAC Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CAVAC Recent Developments
11.7 Komipharm
11.7.1 Komipharm Company Information
11.7.2 Komipharm Overview
11.7.3 Komipharm Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Komipharm Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Komipharm Recent Developments
11.8 Jinyu Bio-Technology
11.8.1 Jinyu Bio-Technology Company Information
11.8.2 Jinyu Bio-Technology Overview
11.8.3 Jinyu Bio-Technology Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Jinyu Bio-Technology Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Jinyu Bio-Technology Recent Developments
11.9 Zoetis
11.9.1 Zoetis Company Information
11.9.2 Zoetis Overview
11.9.3 Zoetis Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Zoetis Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Zoetis Recent Developments
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Company Information
11.10.2 Boehringer Ingelheim Overview
11.10.3 Boehringer Ingelheim Porcine Circovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Boehringer Ingelheim Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Boehringer Ingelheim Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Porcine Circovirus Vaccine Industry Chain Analysis
12.2 Porcine Circovirus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Porcine Circovirus Vaccine Production Mode & Process
12.4 Porcine Circovirus Vaccine Sales and Marketing
12.4.1 Porcine Circovirus Vaccine Sales Channels
12.4.2 Porcine Circovirus Vaccine Distributors
12.5 Porcine Circovirus Vaccine Customers
13 Market Dynamics
13.1 Porcine Circovirus Vaccine Industry Trends
13.2 Porcine Circovirus Vaccine Market Drivers
13.3 Porcine Circovirus Vaccine Market Challenges
13.4 Porcine Circovirus Vaccine Market Restraints
14 Key Findings in The Global Porcine Circovirus Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Porcine Circovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Genetic Engineering Vaccine
Table 3. Major Manufacturers of Killed Vaccines
Table 4. Global Porcine Circovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Porcine Circovirus Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Porcine Circovirus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Porcine Circovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Porcine Circovirus Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Porcine Circovirus Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Porcine Circovirus Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Porcine Circovirus Vaccine Sales by Region (2018-2024) & (M Units)
Table 12. Global Porcine Circovirus Vaccine Sales by Region (2024-2029) & (M Units)
Table 13. Global Porcine Circovirus Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Porcine Circovirus Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Porcine Circovirus Vaccine Sales by Manufacturers (2018-2024) & (M Units)
Table 16. Global Porcine Circovirus Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Porcine Circovirus Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Porcine Circovirus Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Porcine Circovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Porcine Circovirus Vaccine Price by Manufacturers 2018-2024 (USD/K Unit)
Table 21. Global Porcine Circovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Porcine Circovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Circovirus Vaccine as of 2022)
Table 23. Global Key Manufacturers of Porcine Circovirus Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Porcine Circovirus Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Porcine Circovirus Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Porcine Circovirus Vaccine Sales by Type (2018-2024) & (M Units)
Table 28. Global Porcine Circovirus Vaccine Sales by Type (2024-2029) & (M Units)
Table 29. Global Porcine Circovirus Vaccine Sales Share by Type (2018-2024)
Table 30. Global Porcine Circovirus Vaccine Sales Share by Type (2024-2029)
Table 31. Global Porcine Circovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Porcine Circovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Porcine Circovirus Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Porcine Circovirus Vaccine Revenue Share by Type (2024-2029)
Table 35. Porcine Circovirus Vaccine Price by Type (2018-2024) & (USD/K Unit)
Table 36. Global Porcine Circovirus Vaccine Price Forecast by Type (2024-2029) & (USD/K Unit)
Table 37. Global Porcine Circovirus Vaccine Sales by Application (2018-2024) & (M Units)
Table 38. Global Porcine Circovirus Vaccine Sales by Application (2024-2029) & (M Units)
Table 39. Global Porcine Circovirus Vaccine Sales Share by Application (2018-2024)
Table 40. Global Porcine Circovirus Vaccine Sales Share by Application (2024-2029)
Table 41. Global Porcine Circovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Porcine Circovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Porcine Circovirus Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Porcine Circovirus Vaccine Revenue Share by Application (2024-2029)
Table 45. Porcine Circovirus Vaccine Price by Application (2018-2024) & (USD/K Unit)
Table 46. Global Porcine Circovirus Vaccine Price Forecast by Application (2024-2029) & (USD/K Unit)
Table 47. US & Canada Porcine Circovirus Vaccine Sales by Type (2018-2024) & (M Units)
Table 48. US & Canada Porcine Circovirus Vaccine Sales by Type (2024-2029) & (M Units)
Table 49. US & Canada Porcine Circovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Porcine Circovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Porcine Circovirus Vaccine Sales by Application (2018-2024) & (M Units)
Table 52. US & Canada Porcine Circovirus Vaccine Sales by Application (2024-2029) & (M Units)
Table 53. US & Canada Porcine Circovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Porcine Circovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Porcine Circovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Porcine Circovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Porcine Circovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Porcine Circovirus Vaccine Sales by Country (2018-2024) & (M Units)
Table 59. US & Canada Porcine Circovirus Vaccine Sales by Country (2024-2029) & (M Units)
Table 60. Europe Porcine Circovirus Vaccine Sales by Type (2018-2024) & (M Units)
Table 61. Europe Porcine Circovirus Vaccine Sales by Type (2024-2029) & (M Units)
Table 62. Europe Porcine Circovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Porcine Circovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Porcine Circovirus Vaccine Sales by Application (2018-2024) & (M Units)
Table 65. Europe Porcine Circovirus Vaccine Sales by Application (2024-2029) & (M Units)
Table 66. Europe Porcine Circovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Porcine Circovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Porcine Circovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Porcine Circovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Porcine Circovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Porcine Circovirus Vaccine Sales by Country (2018-2024) & (M Units)
Table 72. Europe Porcine Circovirus Vaccine Sales by Country (2024-2029) & (M Units)
Table 73. China Porcine Circovirus Vaccine Sales by Type (2018-2024) & (M Units)
Table 74. China Porcine Circovirus Vaccine Sales by Type (2024-2029) & (M Units)
Table 75. China Porcine Circovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Porcine Circovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Porcine Circovirus Vaccine Sales by Application (2018-2024) & (M Units)
Table 78. China Porcine Circovirus Vaccine Sales by Application (2024-2029) & (M Units)
Table 79. China Porcine Circovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Porcine Circovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Porcine Circovirus Vaccine Sales by Type (2018-2024) & (M Units)
Table 82. Asia Porcine Circovirus Vaccine Sales by Type (2024-2029) & (M Units)
Table 83. Asia Porcine Circovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Porcine Circovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Porcine Circovirus Vaccine Sales by Application (2018-2024) & (M Units)
Table 86. Asia Porcine Circovirus Vaccine Sales by Application (2024-2029) & (M Units)
Table 87. Asia Porcine Circovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Porcine Circovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Porcine Circovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Porcine Circovirus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Porcine Circovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Porcine Circovirus Vaccine Sales by Region (2018-2024) & (M Units)
Table 93. Asia Porcine Circovirus Vaccine Sales by Region (2024-2029) & (M Units)
Table 94. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales by Type (2018-2024) & (M Units)
Table 95. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales by Type (2024-2029) & (M Units)
Table 96. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales by Application (2018-2024) & (M Units)
Table 99. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales by Application (2024-2029) & (M Units)
Table 100. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales by Country (2018-2024) & (M Units)
Table 106. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales by Country (2024-2029) & (M Units)
Table 107. Chopper Biology Company Information
Table 108. Chopper Biology Description and Major Businesses
Table 109. Chopper Biology Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 110. Chopper Biology Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Chopper Biology Recent Developments
Table 112. ChengDu Tecbond Company Information
Table 113. ChengDu Tecbond Description and Major Businesses
Table 114. ChengDu Tecbond Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 115. ChengDu Tecbond Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. ChengDu Tecbond Recent Developments
Table 117. Ringpu Biology Company Information
Table 118. Ringpu Biology Description and Major Businesses
Table 119. Ringpu Biology Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 120. Ringpu Biology Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Ringpu Biology Recent Developments
Table 122. Qilu Animal Company Information
Table 123. Qilu Animal Description and Major Businesses
Table 124. Qilu Animal Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 125. Qilu Animal Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Qilu Animal Recent Developments
Table 127. DHN Company Information
Table 128. DHN Description and Major Businesses
Table 129. DHN Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 130. DHN Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. DHN Recent Developments
Table 132. CAVAC Company Information
Table 133. CAVAC Description and Major Businesses
Table 134. CAVAC Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 135. CAVAC Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. CAVAC Recent Developments
Table 137. Komipharm Company Information
Table 138. Komipharm Description and Major Businesses
Table 139. Komipharm Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 140. Komipharm Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Komipharm Recent Developments
Table 142. Jinyu Bio-Technology Company Information
Table 143. Jinyu Bio-Technology Description and Major Businesses
Table 144. Jinyu Bio-Technology Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 145. Jinyu Bio-Technology Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Jinyu Bio-Technology Recent Developments
Table 147. Zoetis Company Information
Table 148. Zoetis Description and Major Businesses
Table 149. Zoetis Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 150. Zoetis Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Zoetis Recent Developments
Table 152. Boehringer Ingelheim Company Information
Table 153. Boehringer Ingelheim Description and Major Businesses
Table 154. Boehringer Ingelheim Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 155. Boehringer Ingelheim Porcine Circovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Boehringer Ingelheim Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Porcine Circovirus Vaccine Distributors List
Table 160. Porcine Circovirus Vaccine Customers List
Table 161. Porcine Circovirus Vaccine Market Trends
Table 162. Porcine Circovirus Vaccine Market Drivers
Table 163. Porcine Circovirus Vaccine Market Challenges
Table 164. Porcine Circovirus Vaccine Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Porcine Circovirus Vaccine Product Picture
Figure 2. Global Porcine Circovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Porcine Circovirus Vaccine Market Share by Type in 2022 & 2029
Figure 4. Genetic Engineering Vaccine Product Picture
Figure 5. Killed Vaccines Product Picture
Figure 6. Global Porcine Circovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Porcine Circovirus Vaccine Market Share by Application in 2022 & 2029
Figure 8. Piglets
Figure 9. Adults Pigs
Figure 10. Porcine Circovirus Vaccine Report Years Considered
Figure 11. Global Porcine Circovirus Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Porcine Circovirus Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Porcine Circovirus Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Porcine Circovirus Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Porcine Circovirus Vaccine Sales 2018-2029 ((M Units)
Figure 16. Global Porcine Circovirus Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Porcine Circovirus Vaccine Sales YoY (2018-2029) & (M Units)
Figure 18. US & Canada Porcine Circovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Porcine Circovirus Vaccine Sales YoY (2018-2029) & (M Units)
Figure 20. Europe Porcine Circovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Porcine Circovirus Vaccine Sales YoY (2018-2029) & (M Units)
Figure 22. China Porcine Circovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Porcine Circovirus Vaccine Sales YoY (2018-2029) & (M Units)
Figure 24. Asia (excluding China) Porcine Circovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales YoY (2018-2029) & (M Units)
Figure 26. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Porcine Circovirus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Porcine Circovirus Vaccine in the World: Market Share by Porcine Circovirus Vaccine Revenue in 2022
Figure 29. Global Porcine Circovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Porcine Circovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Porcine Circovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Porcine Circovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Porcine Circovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Porcine Circovirus Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Porcine Circovirus Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Porcine Circovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Porcine Circovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Porcine Circovirus Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Porcine Circovirus Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. UK Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Porcine Circovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Porcine Circovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Porcine Circovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Porcine Circovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Porcine Circovirus Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Porcine Circovirus Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Porcine Circovirus Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Porcine Circovirus Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Porcine Circovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Porcine Circovirus Vaccine Value Chain
Figure 80. Porcine Circovirus Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed